* Dolby Laboratories Inc DLB.N DLB is expected to show a
fall
in quarterly revenue when it reports results on May 2 for the
period ending March 31 2024
* The San Francisco California-based company is expected to
report a 4.4% decrease in revenue to $359.442 million from
$375.89 million a year ago, according to the mean estimate from
3 analysts, based on LSEG data.The company's guidance on
February 1 2024, for the period ended March 31, was for revenue
between $345.00 million and $375.00 million. (Sale is on Total
Revenue basis.)
* LSEG's mean analyst estimate for Dolby Laboratories Inc
is for
earnings of $1.19 per share. The company's EPS guidance on
February 1 2024, for the period ended March 31, was between
$1.14 and $1.29
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Dolby
Laboratories Inc is $98.00, above its last closing price
of $77.66.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 0.86 0.86 1.01 Beat 17.4
Sep. 30 2023 0.53 0.53 0.65 Beat 23.4
Jan. 1 0001 0.55 0.55 0.55 Met 0
Mar. 31 2023 0.95 0.98 1.26 Beat 29.2
Dec. 0.78 0.79 1.11 Beat 41.4
31 2022
Sep. 30 2022 0.51 0.60 0.54 Missed -10
Jun. 30 2022 0.59 0.59 0.68 Beat 16.2
Mar. 31 2022 0.82 0.82 0.92 Beat 12.7
This summary was machine generated April 30 at 22:44 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)